Simnet

Simnet is a biotechnology company developing a simulation engine for the immune system to accelerate the discovery and design of novel therapeutics. The company utilizes deep learning and high-throughput experimental data to model how the immune system recognizes and responds to diseases. Simnet's platform is designed to engineer proteins and antibodies with optimized binding and functional properties, targeting complex diseases in oncology and autoimmunity. By bridging the gap between computational modeling and biological reality, the company aims to create more effective and safer immunotherapies. The company's approach integrates advanced AI with proprietary experimental assays to validate designs in real-time.